outcomes research

Research in Review

Internal Radiotherapy Combined With Chemo in Colorectal Liver Metastasis

08/09/2017

JCP Editors

A recent study combined and analyzed data from three trials regarding the use of first-line chemotherapy plus selective internal radiotherapy in patients with colorectal cancer and liver metastases, published in The...

A...

08/09/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Improves Survival in a Subtype of AML

08/04/2017

JCP Editors

Addition of a multi-targeted kinase inhibitor to standard chemotherapy improves outcomes in patients with acute myeloid leukemia (AML) and a specific mutation, according to research published in The New England...

...

08/04/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Works Better in AML Patients With Activated NK Cells

08/03/2017

JCP Editors

The presence of natural killer cells can help keep acute myeloid leukemia (AML) in remission in patients treated with a combination therapy, according to a recent study. ----- Related Content Better AML Outcomes...

The...

08/03/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Optimal Therapy for MCL

08/02/2017

JCP Editors

A recent study showed improved long-term survival outcomes and quality of life (QoL) for patients with mantle cell lymphoma (MCL) receiving tyrosine kinase inhibitor (TKI) therapy compared with those receiving...

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Optimal Therapy for Type of B-Cell Malignancy

08/02/2017

JCP Editors

A...

08/02/2017

Journal of Clinical Pathways

Research in Review

Older Patients With Advanced-Stage Rectal Cancer Often Receive Sub-Optimal Treatment

08/01/2017

JCP Editors

A majority of older patients with stage II or III rectal adenocarcinoma do not receive standard-of-care treatment, according to recent research published in Cancer (online July 31, 2017;...

A...

08/01/2017

Journal of Clinical Pathways

Research in Review

Lymphocyte Biomarkers Predict PFS in HER2-Positive Breast Cancer

07/31/2017

JCP Editors

A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...

A low...

07/31/2017

Journal of Clinical Pathways

Research in Review

ADT Plus Combination Therapy Improves Outcomes in Metastatic Prostate Cancer

07/28/2017

JCP Editors

A combination regimen plus androgen-deprivation therapy prolongs overall survival (OS) and radiographic progression-free survival (PFS) in newly diagnosed patients with metastatic, castration-sensitive prostate...

A...

07/28/2017

Journal of Clinical Pathways

Research in Review

CLL Long-Term Survival Likely to Improve With Novel Therapies

07/26/2017

JCP Editors

Novel agents are predicted to significantly improve lifetime overall survival (OS) and quality-adjusted life-years (QALYs) compared with traditional therapies for patients with chronic lymphocytic leukemia (CLL),...

Novel...

07/26/2017

Journal of Clinical Pathways

Research in Review

Prognostic Implications of ETS2 Expression in AML

07/25/2017

JCP Editors

Elevated expression levels of ETS2 were a strong predictor of prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions, according to recent research published in Journal of...

...

07/25/2017

Journal of Clinical Pathways